-acetylcysteine (NAC) therapy, aligning with renal recovery and reducing apoptosis with enhanced penetration and signal-to-noise ratio, offering a noninvasive platform for early AKI diagnosis, severity assessment, and therapeutic evaluation.
Su et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: